MedPath

IDEA: Intervention to prevent depressive symptoms and promote well-being in early stage dementia

Not Applicable
Completed
Conditions
Early-stage dementia
Mental and Behavioural Disorders
Dementia in Alzheimer disease
Registration Number
ISRCTN75503960
Lead Sponsor
niversity College London
Brief Summary

2018 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/29439085 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/31609689 (added 14/01/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
63
Inclusion Criteria

1. People with mild dementia (MMSE = 20)
2. People with dementia who have received a diagnosis in the last 6 months
3. Living in the community
4. Available family carer who can assist the person with dementia in the intervention and can act as an informant (weekly contact)

Exclusion Criteria

People at risk of suicide (clinicians’ judgement)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Number of eligible participants that consent to the study, and number of those finding<br> the intervention acceptable using 95 Confidence Intervals %<br> 2. Number of dyads recruited per month and any barriers or facilitators to recruitment<br> 3. Follow-up rates and number completing each outcome measure proposed for the main trial<br> 4. Number of sessions attended<br> 5. Standard deviations and correlations between repeated-measurements<br><br> Outcomes will be measured at 4 and 8 months.<br>
Secondary Outcome Measures
NameTimeMethod
<br> People with dementia:<br> 1. Depressive symptoms - Cornell Scale for Depression in Dementia (CSDD)<br> 2. Self-rated and carer-rated dementia-specific quality of life for the person with dementia – DEMQOL<br> 3. Neuropsychiatric symptoms - Neuropsychiatric Inventory (NPI)<br> 4. Health services utilisation - Client Service Receipt Inventory (CSRI)<br><br> Carers:<br> 1. Carers’ mental health - Hospital and Anxiety Depression Scale (HADS)<br> 2. Carers' quality of life - EuroQoL EQ-5D (EQ-5D) and the Short Form-12 Health Survey (SF-12)<br><br> Outcomes will be measured at 4 and 8 months.<br>
© Copyright 2025. All Rights Reserved by MedPath